PDCD1 and acute myeloid leukemia: However, ppp-RNA treatment induces PD-L1 expression on AML cells and establishes therapeutic sensitivity to anti-PD-1 in vivo, the combination of anti-PD-1 and ppp-RNA is superior to either regimen alone in the survival rate of a mouse model (114).